Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 4, 2004, Pages 1093-1097

  Valicenti, Richard K ^a,b   Chervoneva, Inna ^a   Gomella, Leonard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gleason score; Prostate cancer; Radiotherapy; Surgical margins

Indexed keywords

ANTIGENS; DISEASES; DOSIMETRY; PATIENT TREATMENT; SURGERY; TUMORS;

PROSTATECTOMY;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; ANTIGEN DETECTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SCORING SYSTEM; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION;

AGED; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; SEMINAL VESICLES; TREATMENT FAILURE;

EID: 1542376224     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.07.006     Document Type: Article

References (14)

1. D'Amico A., Whittington R., Malkowicz S.B., et al. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins Implications on the use of adjuvant therapy. Urology. 47:1996;538-547.
2. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 71:1993;3582-3593.
3. Catalona W.J., Bhis S.W. Nerve-sparing radical prostatectomy Evaluation of results after 250 patients. J Urol. 143:1990;538-544.
4. Gibbons R.P. Total prostatectomy for clinically localized prostate cancer Long-term surgical results and current morbidity. NCI Monogr. 7:1988;123-126.
5. Stamey T.A., Villers A.A., McNeal J.E., et al. Positive surgical margins at radical prostatectomy Importance of the apical dissection. J Urol. 43:1990;1166-1173.
6. Epstein J.I., Carmichael M., Pizov G., et al. Influence of capsular penetration on progression following radical prostatectomy A study of 196 cases with long-term follow up. J Urol. 150:1993;135-141.
7. Grossfield D.G., Tigrani V.S., Nudell D., et al. Management of a positive surgical margin after radical prostatectomy Decision analysis. J Urol. 164:2000;93-100.
8. Han M., Pound C.R., Potters R., et al. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins. J Urol. 165:2001;864-866.
9. the American Joint Committee on Cancer, Fleming I.D., Cooper J.S., Henson D.E., et al. Manual for staging cancer. 4th ed :1997;JB Lippincott, Philadelphia. 221-224.
10. Tefilli M., Gheiler E., Tiguert R., et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol. 160:1998;802-806.
11. Grossfeld G.D., Chang J.J., Broering J.M., et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment Data from the CaPSURE database. J Urol. 163:2000;1171-1177.
12. Epstein J.I., Pound C.R., Partin A.W., et al. Disease progression following radical prostatectomy in men with Gleason score7 tumor. J Urol. 160:1998;97-101.
13. Ohori M., Wheeler T., Kattan M., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 154:1995;1818-1824.
14. Leibovich B.C., Engen D.E., Patterson D.E., et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol. 163:2000;1178-1182.